Pharm-Olam Reduces Time to Market

 

Having trouble viewing this email? View in Browser With 27 offices among the world's most populated cities, Pharm-Olam provides cost effective coverage in both emerging and traditional markets for Phase I to IV clinical studies. Since 1994 we have used our local knowledge of an investigator's past performance, competing studies, and regulatory environment to offer sponsors an accurate and informed plan to complete trials on time.   Pharm-Olam recently acquired StatWorks, Inc. expanding our data management and biostatistics departments for full service clinical trials and functional outsourcing.   Pharm-Olam is a member of the Clinical Data Interchange Standards Consortium Pharm-Olam International www.pharm-olam.com USA +1 713.559.7900 UK +44 (0) 1344 891121 Full Service Trials and Functional Outsourcing Meet Pharm-Olam at these Conferences SCDM (Baltimore, Sep 11-14) Biotech 2011 (Philadelphia, Oct 24-25) MAGI Clinical Research (Las Vegas, Oct 23-26) Partnerships in Clinical Trials (Lyon, Nov 15-18)

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE